OMXS30, SE0000337842

OMXS30 falls 2.51% as AI concerns weigh on Stockholm stocks

Published on 11/20/2026 at 18:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The OMXS30 fell 2.51% to 3,175.06 points on Friday as concerns about artificial intelligence pressured global equity markets. EQT, SKF and Atlas Copco led declines, while Telia and AstraZeneca finished higher.

Stockholm stocks end a difficult week

  • The OMXS30 fell 2.51% to 3,175.06 points on Friday, November 20.
  • Technology shares underperformed as concerns about artificial intelligence weighed on global equities.
  • EQT, SKF and Atlas Copco were among the sharpest decliners, while Telia and AstraZeneca gained.
OMXS30, SE0000337842, Illustration mit AI erstellt.

The OMXS30 ended Friday, November 20, at 3,175.06 points, down 2.51% from Thursday's close of 3,256.72. The decline left Sweden's leading share index with one of its weakest weeks in recent trading, according to MarketScreener, which cited Finwire.

AI concerns pressure Stockholm

MarketScreener reported that the Stockholm market failed to establish a meaningful advance during the session. Concerns about artificial intelligence developments weighed on US equities and spread to Stockholm and other markets. Technology was the weakest Swedish sector, falling 4.39%, while consumer goods gained 0.60%.

The broader market showed pronounced weakness. Investing.com, carrying a Reuters report, said declining stocks outnumbered advancing shares on the Stockholm Stock Exchange by 606 to 157, with 35 unchanged.

Industrials and financials lead losses

Within the OMXS30, EQT was the weakest performer, falling 5.45% to 288.10 Swedish kronor. AB SKF Class B declined 4.91% to 261.20 Swedish kronor, while Atlas Copco Class A lost 4.36% to 181.95 Swedish kronor. Sandvik fell 3.65% after ABG Sundal Collier removed its buy rating and downgraded the stock to hold, with a price target of 350 Swedish kronor.

The session also brought company-specific developments. Saab declined 2.25% after signing a licensing agreement with Poland's Dezamet for the manufacture and sale of MAPAM mortar ammunition in Poland. Hemnet fell 7.58% after JPMorgan downgraded the company to neutral from overweight and set a price target of 49 Swedish kronor.

Defensive names provide support

Gains in selected defensive and telecom stocks limited the index decline. Telia rose 1.35% to 49.45 Swedish kronor, AstraZeneca added 1.04% to 1,796.00 Swedish kronor and Tele2 Class B gained 0.59% to 162.30 Swedish kronor. MarketScreener reported turnover of approximately 31.8 billion Swedish kronor on the Stockholm exchange.

Further coverage is available on the OMXS30 topic page.

Disclaimer...
en | SE0000337842 | OMXS30 | boerse | 70540829 | bgmi